(Press-News.org) This press release is available in German.
Months of painstaking work in the laboratory at Bielefeld University's Center for Biotechnology (CeBiTec) have paid off: the 15 students participating in this year's 'international Genetically Engineered Machine competition' (iGEM) at the Massachusetts Institute of Technology (MIT) have good reason to celebrate. The goal of their project was to develop a biological filter that removes estrogen from drinking water. It was a success: they managed to produce enzymes that break down the hormone. On Monday 5 November, the competition finals came to a close in Boston. From 190 teams throughout the world, Bielefeld's students made it through to the 'Sweet Sixteen', the selection of the 16 best teams in the company of teams from such prestigious universities as Stanford University (USA), the Canadian University of Calgary, and Jiaotong University in Shanghai, China.
More than 70 teams from throughout the world got through to the finals of the top student competition in synthetic biology. The Bielefeld team was one of five German teams at the start. Bielefeld University has now participated in the iGEM competition for the third year running and already succeeded in qualifying for Boston in 2010 and 2011. This year's team, like its predecessors, made it into the 'Sweet Sixteen'. 'We stand in direct comparison with universities like Stanford and Cornell. At first, that seemed very intimidating, but we soon noticed they were having to fight exactly the same problems as we were. And with our know-how, we can match the pace here', says Moritz Müller, a master student of molecular biotechnology.
Enzymes from fungi growing on trees filter out medicine residues from sewage and drinking water
Conventional methods of filtering waste water in sewage treatment plants are unable to completely remove medicine residues such as the estrogens in birth control pills. These residues then find their way into rivers and lakes and also accumulate in our drinking water. For fish and other aquatic life, estrogens can lead to reproductive and developmental disorders and even to the formation of female characteristics in males. The potential long-term consequences for human beings – declining sperm counts, infertility, various cancers, and osteoporosis – are still largely unknown. The Bielefeld iGEM team has developed a biological filter in which specific enzymes (so-called laccases) break down these medicine residues. One known source of particularly efficient laccases is the turkey tail, a type of fungus that grows on trees. Using methods from synthetic biology, the students succeeded in synthesizing this enzyme and applying it to filter material. 'We didn't want to invent something totally crazy with our project – just because it's technically feasible. We wanted to do something that could actually be put to use in the near future, perhaps in 20 years, and be a real benefit', explains Robert Braun, a master student of molecular biotechnology. 'The biofilter is such a project. And we have shown that our idea works. In principle, a company could now come along and develop our filter further. We ourselves have got to get back to our studies – most of us have rather neglected them for the last 6 months. However, the experiences we have gathered more than compensate for that'.
INFORMATION:
International competition
The iGEM competition has been held every year since 2003 by the Massachusetts Institute of Technology (MIT) in Boston. Starting as an MIT study course, the number of competitors has grown rapidly from five teams in 2004 to 190 in the present year. All teams face the same task: taking their project from the idea across the laboratory work to gaining funding and communicating the findings. On the student level, the iGEM can be seen as the world championship in synthetic biology that shows the future potential of this still young field of research. The Bielefeld iGEM team is being funded by Bielefeld University's Center for Biotechnology (CeBiTec) and the BIO.NRW Cluster Biotechnology North Rhine-Westphalia.
Synthetic biofilter wins through to the top 'Sweet 16' in Boston
Bielefeld students on a par with teams from international elite universities
2012-11-07
ELSE PRESS RELEASES FROM THIS DATE:
Longer use of hormonal contraception during midlife predicts better cognitive function later
2012-11-07
New Rochelle, NY, November 7, 2012—Premenopausal use of hormonal contraceptives may improve the cognitive abilities of women in midlife and for years afterward. This finding may have implications for prevention of declining cognitive function that occurs with advancing age and in diseases such as Alzheimer's. The beneficial effects of hormones increase the longer a woman uses them, as described in a study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health ...
Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
2012-11-07
Contact: Denise Bradley
denise.bradley@tevapharm.com
215-591-8974
Teva North America
Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
Studies highlight safety and efficacy profiles in pediatric patients with seasonal allergic rhinitis, reinforce device functionality and reliability and demonstrate ocular safety profile
JERUSALEM, Israel, November 6, 2012 – Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL® (beclomethasone dipropionate) Nasal Aerosol will be ...
Bone marrow stem cells do not improve short-term recovery after heart attack
2012-11-07
HOUSTON – (Nov. 7, 2012) – Administering stem cells derived from patients' own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health (NIH).
The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function. Both TIME and LateTIME ...
First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
2012-11-07
New Rochelle, NY, November 7, 2012—Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and follow-up care of patients with this extremely aggressive form of thyroid cancer are published in Thyroid (http://www.liebertpub.com/thy), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The Guidelines, prepared by the American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force, are ...
New cell type developed for possible treatment of Alzheimer's and other brain diseases
2012-11-07
Irvine, Calif., Nov. 7, 2012 — UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer's.
Dr. Edwin Monuki of UCI's Sue & Bill Gross Stem Cell Research Center, developmental & cell biology graduate student Momoko Watanabe and colleagues developed these cells –called choroid plexus epithelial cells – from existing mouse and human embryonic stem cell lines.
CPECs are critical for proper functioning of the choroid plexus, the tissue in the brain that produces cerebrospinal fluid. ...
Study shows how to reduce inappropriate shocks from implanted defibrillators
2012-11-07
MAYWOOD, Il. - Loyola University Medical Center is among the centers participating in a landmark study that could lead to fewer inappropriate shocks from implanted defibrillators.
Implanted defibrillators save lives by shocking hearts back into a normal rhythm. But sometimes a defibrillator can go off when it's not necessary, delivering a shock that feels like a kick in the chest.
The study found that reprogramming defibrillators to be less sensitive to irregular heart rhythms reduced the number of inappropriate shocks, while also reducing mortality. The study was presented ...
Researchers explore connection between popular pain relievers, bladder cancer
2012-11-07
(Lebanon, NH, 11/5/2012) — Dartmouth researchers have found that duration of ibuprofen use was associated with a reduced risk of bladder cancer in patients in northern New England, which has a high mortality rate of this disease. In a 2012 collaborative project with the National Cancer Institute, Margaret Karagas, PhD, co-director, Cancer Epidemiology & Chemoprevention program at Norris Cotton Cancer Center, and Professor of Community and Family Medicine at the Geisel School of Medicine at Dartmouth, and Richard Waddell, D.Sc, Research Assistant Professor of Medicine at ...
New drug target found for cystic fibrosis lung disease
2012-11-07
Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation. The finding offers a potential new drug target for treating CF lung disease, which is a major cause of illness and death for people with CF.
"Developing new drugs that target lung inflammation would be a big step forward," says Dr. Stuart Turvey, who led the research. Dr. Turvey is the director of clinical research and senior clinician scientist at the Child & Family Research Institute ...
How butterfly wings can inspire new high-tech surfaces
2012-11-07
COLUMBUS, Ohio – A South American butterfly flapped its wings, and caused a flurry of nanotechnology research to happen in Ohio.
Researchers here have taken a new look at butterfly wings and rice leaves, and learned things about their microscopic texture that could improve a variety of products.
For example, the researchers were able to clean up to 85 percent of dust off a coated plastic surface that mimicked the texture of a butterfly wing, compared to only 70 percent off a flat surface.
In a recent issue of the journal Soft Matter, the Ohio State University engineers ...
DNA sequencing of infants and children with anatomical defects of unknown causes
2012-11-07
A presentation at the American Society of Human Genetics 2012 meeting updated genetics experts about a one-year-old research initiative that brought together researchers, clinicians and policy experts to tackle the challenges of incorporating new genomic technologies into clinical care of newborns, infants and children with anatomical defects whose causes are unknown.
Among the challenges is interpreting how variations in patients' DNA cause or contribute to their medical problems, said Duke University Assistant Professor of Pediatrics Erica E. Davis, Ph.D., who presented ...
LAST 30 PRESS RELEASES:
Successful bone regeneration using stem cells derived from fatty tissue
ELSI to host first PCST Symposium in Japan, advancing science communication across Asia
Researchers improve marine aerosol remote sensing accuracy using multiangular polarimetry
Alzheimer’s Disease can hijack communication between brain and fat tissue, potentially worsening cardiovascular and metabolic health
New memristor wafer integration technology from DGIST paves the way for brain-like AI chips
Bioinspired dual-phase nanopesticide enables smart controlled release
Scientists reveal it is possible to beam up quantum signals
Asymmetric stress engineering of dense dislocations in brittle superconductors for strong vortex pinning
Shared synaptic mechanism for Alzheimer's and Parkinson’s disease unlocks new treatment possibilities
Plasma strategy boosts antibacterial efficacy of silica-based materials
High‑performance wide‑temperature zinc‑ion batteries with K+/C3N4 co‑intercalated ammonium vanadate cathodes
Prioritized Na+ adsorption‑driven cationic electrostatic repulsion enables highly reversible zinc anodes at low temperatures
Engineered membraneless organelles boost bioproduction in corynebacterium glutamicum
Study finds moral costs in over-pricing for essentials
Australian scientists uncover secrets of yellow fever
Researchers develop high-performance biochar for efficient carbon dioxide capture
Biodegradable cesium nanosalts activate anti-tumor immunity via inducing pyroptosis and intervening in metabolism
Can bamboo help solve the plastic pollution crisis?
Voting behaviour in elections strongly linked to future risk of death
Significant variations in survival times of early onset dementia by clinical subtype
Research finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination
Oxford researchers develop ‘brain-free’ robots that move in sync, powered entirely by air
The science behind people who never forget a face
Study paints detailed picture of forest canopy damage caused by ‘heat dome’
New effort launched to support earlier diagnosis, treatment of aortic stenosis
Registration and Abstract Submission Open for “20 Years of iPSC Discovery: A Celebration and Vision for the Future,” 20-22 October 2026, Kyoto, Japan
Half-billion-year-old parasite still threatens shellfish
Engineering a clearer view of bone healing
Detecting heart issues in breast cancer survivors
Moffitt study finds promising first evidence of targeted therapy for NRAS-mutant melanoma
[Press-News.org] Synthetic biofilter wins through to the top 'Sweet 16' in BostonBielefeld students on a par with teams from international elite universities



